Interacting Drugs |
Amlodipine, olmesartan, and hydrochlorothiazide vs Tocilizumab |
Security Level |
 |
Mechanism |
Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates. |
Management |
Monitor therapy |
Amlodipine, olmesartan, and hydrochlorothiazide vs Tocilizumab
Post Review about Amlodipine, olmesartan, and hydrochlorothiazide vs Tocilizumab Click here to cancel reply.
Other Interactions of Amlodipine, olmesartan, and hydrochlorothiazide
Other Interactions of Tocilizumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.